Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary W Miller

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
Molecules (Basel, Switzerland)|October 6, 2018
Bioinspired Honokiol Analogs and Their Evaluation for Activity on the Norepinephrine TransporterKristen Stout, Marketa Bernaskova, Gary W Miller, et al.
Environmental Science. Processes & Impacts|March 12, 2014
Wavelength and temperature-dependent apparent quantum yields for photochemical formation of hydrogen peroxide in seawaterDavid J Kieber, Gary W Miller, Patrick J Neale, et al.
The European Journal of Neuroscience|August 14, 2016
Membrane transporters as mediators of synaptic dopamine dynamics: implications for diseaseKelly M Lohr, Shababa T Masoud, Ali Salahpour, et al.
Neurotoxicology|June 10, 2024
Neurotoxicology of dopamine: Victim or assailant?Meghan L Bucher, Jocelyn Dicent, Carolina Duarte Hospital, et al.
Neurotoxicology|November 14, 2002
Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cellsStacy E Stephans, Gary W Miller, Allan I Levey, et al.
Neuroscience Letters|April 11, 2006
Use-dependent behavioral and neurochemical asymmetry in MPTP miceW Michael Caudle, Jennifer L Tillerson, María E Reverón, et al.
Experimental Neurology|December 4, 2002
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineJennifer L Tillerson, W Michael Caudle, Maria E Reverón, et al.
Current Neurology and Neuroscience Reports|May 22, 2013
Vesicular integrity in Parkinson's diseaseShawn P Alter, Gina M Lenzi, Alison I Bernstein, et al.
Trends in Neurosciences|May 13, 2008
Altered vesicular dopamine storage in Parkinson's disease: a premature demiseW Michael Caudle, Rebecca E Colebrooke, Piers C Emson, et al.
Environmental Health Perspectives|September 4, 2024
Seminar: Functional Exposomics and Mechanisms of Toxicity-Insights from Model Systems and NAMsYunjia Lai, Muhammet Ay, Carolina Duarte Hospital, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Molecules (Basel, Switzerland)|October 6, 2018
Bioinspired Honokiol Analogs and Their Evaluation for Activity on the Norepinephrine TransporterKristen Stout, Marketa Bernaskova, Gary W Miller, et al.
Environmental Science. Processes & Impacts|March 12, 2014
Wavelength and temperature-dependent apparent quantum yields for photochemical formation of hydrogen peroxide in seawaterDavid J Kieber, Gary W Miller, Patrick J Neale, et al.
The European Journal of Neuroscience|August 14, 2016
Membrane transporters as mediators of synaptic dopamine dynamics: implications for diseaseKelly M Lohr, Shababa T Masoud, Ali Salahpour, et al.
Neurotoxicology|June 10, 2024
Neurotoxicology of dopamine: Victim or assailant?Meghan L Bucher, Jocelyn Dicent, Carolina Duarte Hospital, et al.
Neurotoxicology|November 14, 2002
Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cellsStacy E Stephans, Gary W Miller, Allan I Levey, et al.
Neuroscience Letters|April 11, 2006
Use-dependent behavioral and neurochemical asymmetry in MPTP miceW Michael Caudle, Jennifer L Tillerson, María E Reverón, et al.
Experimental Neurology|December 4, 2002
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineJennifer L Tillerson, W Michael Caudle, Maria E Reverón, et al.
Current Neurology and Neuroscience Reports|May 22, 2013
Vesicular integrity in Parkinson's diseaseShawn P Alter, Gina M Lenzi, Alison I Bernstein, et al.
Trends in Neurosciences|May 13, 2008
Altered vesicular dopamine storage in Parkinson's disease: a premature demiseW Michael Caudle, Rebecca E Colebrooke, Piers C Emson, et al.
Environmental Health Perspectives|September 4, 2024
Seminar: Functional Exposomics and Mechanisms of Toxicity-Insights from Model Systems and NAMsYunjia Lai, Muhammet Ay, Carolina Duarte Hospital, et al.
Pageof 22